The group A streptococcal carrier state. A reexamination

Area of Science:

• Infectious Diseases
• Microbiology
• Clinical Medicine

Background:

• Group A beta-hemolytic streptococci (GABHS) cause acute pharyngitis.
• Traditionally, GABHS infection is confirmed by positive throat culture and serologic response, while a positive culture without serologic response indicates a carrier state.
• Streptococcal carriers are presumed to have minimal clinical response to antibiotic therapy.

Purpose of the Study:

• To investigate the clinical response to antibiotic therapy in patients with acute pharyngitis.
• To evaluate the utility of streptococcal antibody titers in differentiating true GABHS infections from carrier states.

Main Methods:

• Patients with acute pharyngitis were categorized into three groups: negative throat culture (Group 1), positive throat culture with significant antibody rise (Group 2), and positive throat culture without significant antibody rise (Group 3).
• Clinical responses to antibiotic therapy were compared across the three groups.

Main Results:

• Patients in Group 2 and Group 3 exhibited comparable and significant clinical improvement following antibiotic treatment.
• The clinical response in Groups 2 and 3 was markedly greater than in Group 1 (negative throat culture).
• Antibiotic therapy yielded substantial clinical benefits for patients with positive throat cultures, irrespective of their antibody response.

Conclusions:

• The findings question the established criteria for distinguishing between GABHS infection and carrier states using antibody responses.
• Antibiotic therapy appears beneficial for acute pharyngitis in patients with positive throat cultures, even without a significant serologic response.
• Further research is warranted to refine diagnostic and treatment guidelines for streptococcal pharyngitis.